Phase II, randomized, double-blind placebo-controlled trial of nimotuzumab plus gemcitabine compared with gemcitabine alone in patients (pts) with advanced pancreatic cancer (PC)

Copy For Citation

Strumberg D., Schultheis B., Ebert M. P., Kerkhoff A., Hofheinz R. D., Behringer D. M., ...More

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 31
• City: Illinois
• Country: United States Of America
• Hacettepe University Affiliated: Yes